-
Botulinum Toxin Type-A — Korean Brand Clinical Survey 2026
A journal-of-medicine reading of the Korean botulinum toxin type-A landscape in 2026 — what MFDS clearance distinguishes between Hutox, Nabota, Coretox, Meditoxin, Wonder-Tox, and Liztox, and how the
-
Korean Aesthetic Medicine Statistics Survey 2026
A clinical-evidence reading of the Korean aesthetic-medicine landscape through KHIDI medical-tourism receipts, MFDS device clearance counts, MOHW physician licensure, and the procedure-category share
-
PDLLA (Juvelook) vs Sculptra (PLLA) — A 2026 Korean Clinical Comparison
A journal-of-medicine reading of the two principal poly-lactic-acid biostimulators in 2026 — Juvelook (PDLLA, VAIM Global, MFDS-cleared 2020) and Sculptra (PLLA, Galderma, US FDA 1999) — across molecu
-
Juvelook (PDLLA) + MFU Combination — A Korean Clinical Reading
A journal-of-medicine reading of the Juvelook PDLLA microsphere booster stacked with microfocused ultrasound lifting in Korea in 2026 — what the published literature actually shows about the layered p
-
Korean Aesthetic Medicine Decade — A Clinical Retrospective 2026
A journal-of-medicine reading of Korea's aesthetic-medicine decade — Rejuran 2014, Ultherapy 2015, Juvelook 2020, ASCE+ exosome 2024 — against MFDS clearance, the published Korean clinical record, and
-
Korean Laser Clinical Evidence Survey 2026
A clinical-evidence reading of the Korean laser landscape — picosecond, fractional CO2, IPL, pulsed-dye, Q-switched, and carbon toning — through the lens of MFDS device class, KSLMS consensus, and the
-
Hydrodermabrasion / Aqua Peel — Device Categorization and Clinical Reading
Hydrodermabrasion, often marketed in Korea as aqua peel, hydro peel, or hydrafacial, is a category of vacuum-assisted serum-infusion devices that exfoliate the stratum corneum while delivering aqueous
-
Non-Surgical Nose Augmentation in Korea — A 2026 Clinical Reading
A clinical-literature reading of non-surgical nose augmentation as practised in Korean clinics in 2026 — what the dorsum, tip, and columellar protocols actually do, what the vascular-safety record loo
-
Rejuran vs Plinest — Polynucleotide Clinical Comparison 2026
A journal-of-medicine reading of the two anchor polynucleotide skin boosters available in Korea in 2026 — Rejuran from Pharma Research and Plinest from Mastelli — with attention to molecular source, p
-
Exosome vs PDRN vs Skin Booster — A Korean Clinical Comparison
A journal-of-medicine reading of the regenerative trio in Korea in 2026 — what the published literature actually shows about exosome paracrine signalling, PDRN tissue repair, and the broader skin-boos
-
PDLLA Microsphere Clinical Evidence — A 2026 Korean Survey
A journal-of-medicine reading of PDLLA microsphere biostimulators in Korea in 2026 — what the published literature actually shows, what the MFDS clearance record covers, and how senior Seoul houses se
-
Stem Cell Aesthetic Medicine in Korea — Regulatory Class & Clinical Reading
A journal-of-medicine reading of the Korean stem cell aesthetic regulatory framework — the MFDS class assignment, the MOHW Advanced Regenerative Medicine Center designation pathway, the autologous-ver